| Financial Year |
March 31 2023 |
| Monetary Funds |
13,670,755,720.72 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
193,494,675.20 |
| Accounts Receivable |
18,532,894,192.30 |
| Advances to Suppliers |
1,975,089,508.17 |
| Other Receivables |
1,646,829,737.95 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
402,978,696.84 |
| Inventories |
764,054,904.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
82,327,953.05 |
| Other Current Assets |
1,302,028,616.04 |
| Total Current Assets |
38,425,639,287.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,400,000.00 |
| Long-term Equity Investment |
16,075,635,967.12 |
| Investment Properties |
132,744,468.26 |
| Fixed Assetes |
93,697,857,849.40 |
| Under-construction Projects |
8,136,854,525.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,759,288,861.59 |
| R&D expenses |
-- |
| Goodwill |
5,456,337.47 |
| Long-Term Deferred and Prepaid Expenses |
114,521,359.05 |
| Deferred Income Tax Assets |
186,517,565.17 |
| Other Non-Current Assets |
4,020,613,095.21 |
| Sub-Total of Non-Current Assets |
131,060,138,606.32 |
| Total Assets |
169,485,777,893.53 |
| Short-Term Loans |
18,612,216,819.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,421,966.27 |
| Accounts Payable |
9,425,957,720.94 |
| Accounts Received In Advance |
12,091,306.94 |
| Employee Compensation Payable |
168,161,262.27 |
| Taxes Payable |
491,029,412.60 |
| Interest Payable |
-- |
| Dividend Payable |
358,635,851.68 |
| Other payables |
3,814,193,614.68 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,641,920,326.19 |
| Other Current Liabilities |
6,370,796,750.38 |
| Sub-Total of Current Liabilities |
42,822,863,740.43 |
| Long-term Loans |
55,305,925,310.78 |
| Bonds Payable |
7,000,000,000.00 |
| Long-Term Accounts Payable |
11,344,880,796.60 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
379,672,229.84 |
| Other Non-Current Liabilities |
862,867,530.09 |
| Sub-Total of Non-Current Liabilities |
78,544,098,845.40 |
| Total Liabilities |
121,366,962,585.83 |
| Paid-In Capital(Or Share Stock) |
2,816,743,645.00 |
| Capital Surplus |
7,666,923,004.96 |
| Surplus Reserve |
1,079,123,159.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,038,007,550.07 |
| Minority Stockholder's Interest |
26,502,541,084.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
21,616,274,223.70 |
| Owner's Equity（Stockholder's Equity） |
48,118,815,307.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
169,485,777,893.53 |
